WHO releases new target product profiles for urgently needed antibiotics: Geneva Thursday, March 12, 2026, 09:00 Hrs [IST] The World Health Organization (WHO) published three new ...

A newly developed antibiotic called EVG7 could offer a powerful new way to stop Clostridioides difficile, a dangerous gut bacterium that often returns after treatment. In mouse studies, researchers ...

A communication pathway between the brain and the gut may be integral to how well the brain holds on to memories.

Scientists have created a genomic blueprint for Aeromonas bacteria, which can cause antibiotic-resistant diarrheal disease—with symptoms often misidentified as cholera—in humans and animals.

Antibiotics are designed to wipe out infection-causing bacteria, but even a single course can leave a lasting mark on the gut microbiome, according to a new study of nearly 15,000 adults in Sweden.

Drugmakers must focus on developing new antibiotics to fight hospital “superbugs” including meningitis and other infections that can resist last-line treatments, the World Health Organization (WHO) ...

We need a reliable pipeline with new antibacterial agents that are innovative, affordable, accessible to all those who need ...

Emerging studies suggest postbiotics could aid PCOS management by restoring gut microbiome balance and enhancing insulin sensitivity and hormonal regulation.

A bacterium already famous for shrugging off extreme radiation and desiccation has now passed another brutal test: surviving ...

Lead clinical candidate CTX-187 is a novel antimicrobial immunotherapy developed to treat clinically-prevalent and multi-drug resistant Gram-negative bacterial infections Qualified Infectious Disease ...

Lead clinical candidate CTX-187 is a novel antimicrobial immunotherapy developed to treat clinically-prevalent and multi-drug resistant Gram-negative bacterial infections -- Qualified Infectious ...